manilatimes20h
SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
STRACON Group Announces Listing on the Lima Stock Exchange, Expanding Presence in Key Latin American Markets
Engineering & Technology: Under the STRACON Engineering & Tech brand, this segment delivers integrated engineering, procurement, and construction solutions, alongside operational and information ...
Arizona Daily Star20h
Rio Nuevo partners with UA Athletics to promote ‘connectivity’ to downtown Tucson
Rio Nuevo approved a $100,000 marketing partnership with the University of Arizona athletic department to promote downtown ...
Business Insider19h
Business Insider: The Latest
Explore our 2025 review of Betterment, a top-notch robo-advisor for personalized, automated investment management and financial planning services. Read our 2025 Stash Investing review and explore ...